Brain atrophy in relapsing-remitting multiple sclerosis: Fractional volumetric analysis of gray matter and white matter

Radiology

Volumn 220, Issue 3, 2001, Pages 606-610

  Ge, Y ^a   Grossman, R I ^a   Udupa, J K ^a   Babb, J S ^a   Nyul L G ^a   Kolson, D L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

10.121411; 10.121419; 10.871; 10.88; Brain; Gray matter; MR; Multiple; Sclerosis; Volume; White matter

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISABILITY; FEMALE; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT OUTCOME; WHITE MATTER;

EID: 0034866802     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2203001776     Document Type: Article

References (29)

1. The pathology of multiple sclerosis
2. Chronic progressive multiple sclerosis: Relationship between cerebral ventricular size and neuropsychological impairment
3. Multiple sclerosis and corpus callosum atrophy: Relationship of MRI findings to clinical data
4. A longitudinal study of brain atrophy in relapsing-remitting multiple sclerosis
5. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
6. Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI
7. Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: Quantitative MR assessment
8. Cortical lesions in multiple sclerosis
9. MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing
10. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis
11. Serial gadolinium-enhanced MRI in relapsing-remitting multiple sclerosis of varying disease duration
12. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
13. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS)
14. 3DVIEWNIX: An open, transportable, multidimensional, multimodality, multiparametric imaging software system
15. Fuzzy connectedness and object definition: Theory, algorithms and applications in imaging segmentation
16. Multiple sclerosis lesion quantification using fuzzy connectedness principles
17. Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging
18. Frontotemporal dementia and Alzheimer disease: Evaluation of cortical atrophy with automated hemispheric surface display generated with MR images
19. Corticobasal degeneration: Neurologic and clinical heterogeneity
20. Axonal transaction in the lesions of multiple sclerosis
21. The longstanding MS lesion: A quantitative MRI and electron microscopy study
22. Histopathological correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
23. Accumulation of hypointense lesions ("black holes") on T1 spin echo MRI correlates with disease progression in multiple sclerosis
24. 1H MRSI of normal appearing white matter in multiple sclerosis
25. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
26. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis
27. Progressive cerebral atrophy in multiple sclerosis: A serial MRI study
28. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis